The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
We would like to notify that within the fourteenth meeting of the Vienna Economic Forum “Vienna future dialogue 2017” Ognian Donev PhD, Chairman of the Board of Directors and Executive Director of Sopharma AD received the Forum award for “Contribution to the economic development on national and regional level”.
We would like to notify that the company BRIZ, a subsidiary of Sopharma, operating on the markets of the Baltics and Belarus, which turned 26 this year, was awarded with the Paracelsus award.
We would like to notify that an Annual meeting with the investors of Sopharma AD was held on 3 November 2017, which started at 2.30 pm and ended at 6.30 pm. The following announcement regarding the liability was made:
Sopharma AD notifies that for October 2017 the Company recorded an increase of sales revenues of 7% compared to the same month of 2016, including 3% increase of domestic sales and 12% increase of export sales.
For the first ten months of this year, revenues from sales increased by 12% compared to the same period of 2016, including 2% decrease of domestic sales and a 23% increase of export sales.